Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Abiomed Stock Is Falling Today


Shares of Abiomed (NASDAQ: ABMD) dropped about 11% as of 12:39 p.m. EST on Monday. The double-digit plunge is traceable to a pair of clinical studies that were presented over the weekend that raise new questions about the usefulness of the company's Impella heart pumps.

Two research teams presented data over the weekend at the American Heart Association's annual meeting in Philadelphia that questioned the safety and effectiveness of Abiomed's Impella heart pumps.

The studies found that Impella is "associated with an increased risk of death, bleeding, and stroke among patients undergoing angioplasty to reopen clogged arteries."

Continue reading


Source Fool.com

Like: 0
Share

Comments